Results 111 to 120 of about 5,900 (176)

Identification of a Novel NPC1L1 Inhibitor from Danshen and Its Role in Nonalcoholic Fatty Liver Disease

open access: yes
Danshen, a well-known traditional Chinese medicine (TCM), has gained increasing attention for its protective effects on nonalcoholic fatty liver disease (NAFLD). However, the molecular mechanisms underlying these effects remain to be elucidated.
Donghai Xia   +9 more
core   +1 more source

Therapeutic Potential of <i>Salvia miltiorrhiza</i> in Glioblastoma: Evidence from in vitro and in vivo Studies. [PDF]

open access: yesInt J Gen Med
Lee CC   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy